OCGN Christopher L. Jacobs buys between 15,001 and 50,000 shares
Jan 01, 2025, 2:44 AM
-8.37%
What does OCGN do
Ocugen is a biopharmaceutical company based in Malvern, Pennsylvania, focused on gene and cell therapies for eye diseases, including inherited retinal disorders. The company also develops inhalation-based vaccines for COVID-19 and seasonal flu.
Representative Christopher L. Jacobs bought between 15,001 and 50,000 shares of OCGN on 16 June.
📡️ Health Care
Politician Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.